Amonafide as first-line chemotherapy for metastatic breast cancer
Authors:
- M RadererMRM Raderer
- D DepischDDD Depisch
- K HaiderKHK Haider
- B FazenyBFB Fazeny
- C DittrichCDC Dittrich
- W ScheithauerWSW Scheithauer
- 1 January 1994
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer
- Vol. 30 (3) , 398-400
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Evaluation of Amonafide in Cervical Cancer, Phase IIAmerican Journal of Clinical Oncology, 1992
- Paradoxical relationship between acetylator phenotype and amonafide toxicityClinical Pharmacology & Therapeutics, 1991
- Phase II study of amonafide in advanced breast cancerBreast Cancer Research and Treatment, 1991
- Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.Journal of Clinical Oncology, 1990
- Amonafide in metastatic colorectal carcinomaEuropean Journal of Cancer and Clinical Oncology, 1990
- Phase I clinical investigation of amonafide.Journal of Clinical Oncology, 1989
- Reporting results of cancer treatmentCancer, 1981
- Synthesis and mode(s) of action of a new series of imide derivatives of 3-nitro-1,8 naphthalic acidCancer Chemotherapy and Pharmacology, 1980